152 related articles for article (PubMed ID: 6602672)
1. Circulating immune complexes in toxoplasmosis: detection and clinical correlates.
Siegel JP; Remington JS
Clin Exp Immunol; 1983 Apr; 52(1):157-63. PubMed ID: 6602672
[TBL] [Abstract][Full Text] [Related]
2. [Circulating immune complexes: optimization and characteristics of the C1q(I125) fixation test].
Caillot G; Lamelin JP; Hartmann DJ; Ville G
Pathol Biol (Paris); 1984 Nov; 32(9):931-7. PubMed ID: 6334270
[TBL] [Abstract][Full Text] [Related]
3. Circulating immune complexes in Lyme arthritis. Detection by the 125I-C1q binding, C1q solid phase, and Raji cell assays.
Hardin JA; Walker LC; Steere AC; Trumble TC; Tung KS; Williams RC; Ruddy S; Malawista SE
J Clin Invest; 1979 Mar; 63(3):468-77. PubMed ID: 429566
[TBL] [Abstract][Full Text] [Related]
4. Circulating immune complexes in rheumatic fever.
Kawakami K; Hokonohara M; Miyata K; Terawaki T
Jpn Circ J; 1982 Nov; 46(11):1188-91. PubMed ID: 6982348
[TBL] [Abstract][Full Text] [Related]
5. Circulating immune complexes in human acute leukaemia.
Balestrieri G; Tincani A; Cattaneo R; Rossi G; Verzura P; Marini G; Calculli G; Ferremi P; Marinone G
Br J Haematol; 1981 Oct; 49(2):269-74. PubMed ID: 6975116
[TBL] [Abstract][Full Text] [Related]
6. Detection and partial characterization of immune complexes in patients with rheumatoid arthritis plus Sjogren's syndrome and with Sjogren's syndrome alone.
Yoshinoya S; McDuffy S; Alarcon-Segovia D; Pope RM
Clin Exp Immunol; 1982 May; 48(2):339-47. PubMed ID: 6980743
[TBL] [Abstract][Full Text] [Related]
7. Critical aspects of the 125I-C1q binding assay for detecting immune complexes in tumor patients.
Krieger G; Bause I; Kneba M; Kehl A; Nagel GA
J Clin Lab Immunol; 1984 Jun; 14(2):87-92. PubMed ID: 6611419
[TBL] [Abstract][Full Text] [Related]
8. Circulating antigen-antibody complexes in onchocerciasis.
Steward MW; Sisley B; Mackenzie CD; El Sheikh H
Clin Exp Immunol; 1982 Apr; 48(1):17-24. PubMed ID: 6979445
[TBL] [Abstract][Full Text] [Related]
9. C1q binding activity in the sera of patients with chronic lung diseases.
Cooper KM; Moore M; Hilton AM
Clin Exp Immunol; 1981 Jul; 45(1):18-28. PubMed ID: 6975678
[TBL] [Abstract][Full Text] [Related]
10. The complement fixing ability of putative circulating immune complexes in rheumatoid arthritis and its relationship to extra-articular disease.
Bourke BE; Moss IK; Mumford P; Horsfall A; Maini RN
Clin Exp Immunol; 1982 Jun; 48(3):726-32. PubMed ID: 6981475
[TBL] [Abstract][Full Text] [Related]
11. Polyethylene glycol enhances the binding of C1q to circulating immune complexes.
Hack CE; Eerenberg-Belmer AJ; Hannema AJ; Out TA; Aalberse RC
J Immunol Methods; 1981; 44(2):211-21. PubMed ID: 6792284
[TBL] [Abstract][Full Text] [Related]
12. The use of TNP-conjugated polyacrylamide beads in a C1q binding inhibition test for circulating immune complexes.
Schmidt R; Walther S; Sodomann CP
Immunobiology; 1982; 162(2):153-64. PubMed ID: 6981581
[TBL] [Abstract][Full Text] [Related]
13. Circulating immune complexes in the serum in systemic lupus erythematosus and in carriers of hepatitis B antigen. Quantitation by binding to radiolabeled C1q.
Nydegger UE; Lambert PH; Gerber H; Miescher PA
J Clin Invest; 1974 Aug; 54(2):297-309. PubMed ID: 4847246
[TBL] [Abstract][Full Text] [Related]
14. The complement subcomponent C1q mediates binding of immune complexes and aggregates to endothelial cells in vitro.
Daha MR; Miltenburg AM; Hiemstra PS; Klar-Mohamad N; Van Es LA; Van Hinsbergh VW
Eur J Immunol; 1988 May; 18(5):783-7. PubMed ID: 3259929
[TBL] [Abstract][Full Text] [Related]
15. Chronic liver disease: the detection and characterization of circulating immune complexes.
Brown SE; Steward MW; Viola L; Howard CR; Murray-Lyon IM
Immunology; 1983 Aug; 49(4):673-83. PubMed ID: 6307866
[TBL] [Abstract][Full Text] [Related]
16. [Are C1q binding immune complexes appropriate as markers for infected ventriculo-atrial shunts?].
Samtleben W; Etou A
Immun Infekt; 1986 Jul; 14(4):148-51. PubMed ID: 3488953
[TBL] [Abstract][Full Text] [Related]
17. Circulating immune complexes in cervical cancer patients as detected by C1q binding.
Chao KC; Liu CC; Ng HT; Hu CP; Chang CM
Proc Natl Sci Counc Repub China B; 1984 Jan; 8(1):50-3. PubMed ID: 6335756
[TBL] [Abstract][Full Text] [Related]
18. The [125I]C1q binding assay for the detection of soluble immune complexes.
Zubler RH; Carpentier N; Lambert PH
Methods Enzymol; 1981; 74 Pt C():530-7. PubMed ID: 6976503
[No Abstract] [Full Text] [Related]
19. [Demonstration of IgM-antitoxoplasma antibodies in acute and chronic acquired human toxoplasmosis].
Thiermann E; Stagno S
Zentralbl Bakteriol Orig A; 1972 Feb; 219(2):249-63. PubMed ID: 4146139
[No Abstract] [Full Text] [Related]
20. 125I-C1q binding activity of soluble antigen-antibody complexes formed in vitro.
Soltis RD; Hasz DE
J Clin Lab Immunol; 1982 Nov; 9(2):121-31. PubMed ID: 6984078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]